Fortis Group Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Sell
718
-1,353
-65% -$315K 0.03% 269
2026
Q1
$489K Sell
2,071
-7,499
-78% -$1.75M 0.08% 185
2025
Q4
$2.16M Buy
9,570
+7,202
+304% +$1.42M 0.36% 68
2025
Q3
$444K Buy
2,368
+1,464
+162% +$251K 0.08% 167
2025
Q2
$138K Buy
904
+32
+4% +$4.92K 0.03% 221
2025
Q1
$145K Sell
872
-1,658
-66% -$259K 0.03% 191
2024
Q4
$366K Hold
2,530
0.07% 150
2024
Q3
$410K Buy
2,530
+57
+2% +$9.08K 0.08% 141
2024
Q2
$361K Sell
2,473
-528
-18% -$78.5K 0.07% 135
2024
Q1
$475K Sell
3,001
-493
-14% -$78.5K 0.09% 134
2023
Q4
$545K Buy
3,494
+996
+40% +$153K 0.13% 68
2023
Q3
$388K Buy
2,498
+520
+26% +$85.8K 0.12% 80
2023
Q2
$327K Buy
1,978
+476
+32% +$76.8K 0.09% 102
2023
Q1
$246K Buy
+1,502
New +$243K 0.07% 109
2020
Q3
$547K Buy
+3,681
New +$545K 0.11% 97

Other funds holding JNJ

Fortis Group Advisors's JNJ Position: Q2 2026 in Review

Fortis Group Advisors reduced its Johnson & Johnson (JNJ) stake by 65% in Q2 2026, selling an estimated $315K and leaving 718 shares worth $182K. The position accounts for 0.03% of the portfolio, ranked #269.

Fortis Group Advisors first reported a position in JNJ in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.16M in Q4 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fortis Group Advisors held 718 shares of Johnson & Johnson worth $182K as of Q2 2026.
  • Fortis Group Advisors sold 1,353 Johnson & Johnson shares in Q2 2026, an estimated $315K.
  • Johnson & Johnson made up 0.03% of Fortis Group Advisors's portfolio in Q2 2026, its #269 holding.
  • Fortis Group Advisors first reported a position in Johnson & Johnson in Q3 2020 and has held it in 15 quarters since.
  • Fortis Group Advisors's Johnson & Johnson position peaked at $2.16M in Q4 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.